A study confirms that Alzheimer’s disease biomarkers exist in the vitreous, and their correlation to cognition suggest that protein biomarkers in the vitreous has a potential role as an early diagnostic tool.
Growing bodies of evidence suggest anti-VEGF injections can lead to “robust” improvements in diabetic retinopathy, explains Charles C. Wykoff, MD, PhD.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%